EFFECTS OF 2-{4-(2-IMIDAZO[1, 2-a]PYRIDYL)PHENYL} PROPIONIC ACID (Y-9213) AND ANTI-INFLAMMATORY DRUGS ON ERYTHROCYTES, POLYMORPHONUCLEAR LEUKOCYTES AND LYSOSOMES IN VITRO
スポンサーリンク
概要
- 論文の詳細を見る
2-{4-(2-Imidazo[1, 2-a]pyridyl)phenyl}propionic acid (Y-9213) with analgesic, antipyretic and anti-inflammatory activities significantly inhibited hemolysis of rat erythrocytes. Activity of Y-9213 (100-500 μM) on hemolysis was more potent than that of phenylbutazone, and less potent than that of indomethacin. The spontaneous release of enzymes from rat liver lysosomes by incubation alone was significantly inhibited by Y-9213 (1-100 μM) to the same degree as phenylbutazone or tinoridine hydrochloride. Release of enzymes from the lysosomes by addition of phospholipase C (PLC, 0.03 units/ml) was slightly inhibited by Y-9213 (10-100 μM) and phenylbutazone (100 μM). Dexamethasone, prednisolone, hydrocortisone and tinoridine hydrochloride (1-10 μM) inhibited more potently the PLC-induced release than the spontaneous release. Y-9213 (1-100 μM) inhibited considerably the release of enzymes from intact lysosomes of rabbit polymorphonuclear (PMN) leukocytes. The release of enzymes from the PMN leukocyte lysosomes preincubated at 37°C for 15 min was strongly inhibited by dexamethasone, prednisolone and hydrocortisone (1-100 μM), but not by Y-9213, phenylbutazone and indomethacin (100 μM). Y-9213 (0.1-10 μM) also inhibited significantly the phagocytic secretion of lysosomal enzymes from PMN leukocytes without affecting phagocytosis of the particles. Activity of this agent was similar to that of phenylbutazone, and less active than that of indomethacin, dexamethasone or prednisolone. Our results suggest that Y-9213 may stabilize membranes of erythrocytes and lysosomes and inhibit phagocytic secretion of lysosomal constituents from PMN leukocytes.
- 社団法人 日本薬理学会の論文
著者
-
Maruyama Yutaka
Research Laboratories Yoshitomi Pharmacoceutical Industries Ltd.
-
Hisadome Masao
Research Laboratories Yoshitomi Pharmaceutical Industries Ltd.
-
IMAMURA HIROSHI
Research Laboratories, Yoshitomi Pharmacoceutical Industries Ltd.
-
GOTO KAZUHIRO
Research Laboratories, Yoshitomi Pharmaceutical Industries Ltd.
関連論文
- Evaluation of combined antibiotic-omeprazole therapies in Helicobacter pylori-infected Mongolian gerbils
- EFFECT OF SUFOXAZINE (Y-8894) ON LEARNING AND MEMORY IN ANIMALS
- IMMUNOPHARMACOLOGICAL PROPERTIES OF NEW ANTIALLERGIC AGENT Y-12,141
- EFFECTS OF BUFETOLOL AND PROPRANOLOL ON ACTIVE AND PASSIVE MEMBRANE PROPERTIES OF DOG PAPILLARY MUSCLE
- EFFECTS OF 2-{4-(2-IMIDAZO[1, 2-a]PYRIDYL)PHENYL} PROPIONIC ACID (Y-9213) ON IN VIVO RELEASE OF LYSOSOMAL ENZYMES FROM RAT POLYMORPHONUCLEAR LEUKOCYTES DURING PHAGOCYTOSIS OF PARTICLES
- EFFECTS OF 2-{4-(2-IMIDAZO[1, 2-a]PYRIDYL)PHENYL} PROPIONIC ACID (Y-9213) AND ANTI-INFLAMMATORY DRUGS ON ERYTHROCYTES, POLYMORPHONUCLEAR LEUKOCYTES AND LYSOSOMES IN VITRO
- ANTI-ANAPHYLACTIC ACTIVITIES OF A NEW BENZOPYRANOPYRIDINE DERIVATIVE Y-12, 141 IN RATS AND GUINEA PIGS
- TRAXANOX AUGMENTS IMMUNE RESPONSE TO LIPOPOLYSACCHARIDE IN INBRED MICE: ROLE OF MACROPHAGES
- PHARMACOLOGICAL STUDIES ON 8-[(1, 4-BENZODIOXAN-2-YL) METHYL]-3-OXO-1-THIA-4, 8-DIAZASPIRO-[4, 5]-DECANE MALEATE
- Stimulation of phagocytic activity of leukocytes and macrophages by traxanox sodium in mice and rats.
- Effect of cysteine ethylester hydrochloride (CystaninR) on host defense mechanisms. (IV). Potentiating effects on the function of peritoneal or spleen macrophages.
- An antagonistic activity of etizolam on platelet-activating factor(PAF). In vitro effects on platelet aggregation and PAF receptor binding.
- Effect of etizolam (Depas) on production of superoxide anion by platelet-activating factor and N-formyl-methionyl-leucyl-phenylalanine-stimulated guinea pig polymorphonuclear leukocytes.
- Effect of cysteine ethylester hydrochloride (Cystanin) on host defense mechanisms (V): Potentiation of nitroblue tetrazolium reduction and chemiluminescence in macrophages or leukocytes of mice or rats.